Teleflex Announces That Arrow International Has Received FDA Corporate Warning Letter

Posted by Patrick McDowell in Health News | Comments Off

Teleflex Incorporated (NYSE:TFX) has announced that its subsidiary, Arrow International (Arrow) has received a corporate warning letter from the Philadelphia District Office of the U.S. Food and Drug Administration (FDA). [click link for full article]